Industry Research Reports
Home > Reports > Medical Devices & Consumables > Adaptive Neuromodulation Therapy Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Adaptive Neuromodulation Therapy Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Industry: Medical Devices & Consumables
Published Date: 2026-01-19
Pages: 87 Pages
Report ld: 5731298
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global market for Adaptive Neuromodulation Therapy Devices was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Adaptive Neuromodulation Therapy Devices cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Deep brain stimulation is an established technique for the treatment of movement disorders related to neurodegenerative diseases such as Parkinson's disease (PD) and essential tremor (ET). Its application seems also feasible for the treatment of neuropsychiatric disorders such as treatment resistant depression (TRD) and Tourette's syndrome (TS). In a typical deep brain stimulation system, the amount of current delivered to the patients is constant and regulated by the physician. Conversely, an adaptive deep brain stimulation system (aDBS) is a closed loop system that adjusts the stimulation parameters according to biomarkers which reflect the patient's clinical state.
The North American market for Adaptive Neuromodulation Therapy Devices was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Adaptive Neuromodulation Therapy Devices was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Adaptive Neuromodulation Therapy Devices was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Adaptive Neuromodulation Therapy Devices market include Medtronic plc, Amber Therapeutics, Newronika SPA, Genlight, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Adaptive Neuromodulation Therapy Devices, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Adaptive Neuromodulation Therapy Devices market size, estimations, and forecasts are presented in terms of sales volume (Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Adaptive Neuromodulation Therapy Devices.
MARKET SEGMENTATION
By Company
- Medtronic plc
- Amber Therapeutics
- Newronika SPA
- Genlight
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Single-channel
- Dual Channels
Segment by Application
- Epilepsy
- Parkinson's Disease (PD)
- Mixed urinary incontinence (MUI)
- Other
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Adaptive Neuromodulation Therapy Devices manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Adaptive Neuromodulation Therapy Devices sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Adaptive Neuromodulation Therapy Devices sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Adaptive Neuromodulation Therapy Devices Product Introduction
1.2 Global Adaptive Neuromodulation Therapy Devices Market Size Forecast
1.2.1 Global Adaptive Neuromodulation Therapy Devices Sales Value (2021–2032)
1.2.2 Global Adaptive Neuromodulation Therapy Devices Sales Volume (2021–2032)
1.2.3 Global Adaptive Neuromodulation Therapy Devices Sales Price (2021–2032)
1.3 Adaptive Neuromodulation Therapy Devices Market Trends & Drivers
1.3.1 Adaptive Neuromodulation Therapy Devices Industry Trends
1.3.2 Adaptive Neuromodulation Therapy Devices Market Drivers & Opportunities
1.3.3 Adaptive Neuromodulation Therapy Devices Market Challenges
1.3.4 Adaptive Neuromodulation Therapy Devices Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Adaptive Neuromodulation Therapy Devices Players Revenue Ranking (2025)
2.2 Global Adaptive Neuromodulation Therapy Devices Revenue by Company (2021–2026)
2.3 Global Adaptive Neuromodulation Therapy Devices Sales Volume Ranking of Players (2025)
2.4 Global Adaptive Neuromodulation Therapy Devices Sales Volume by Company (2021–2026)
2.5 Global Adaptive Neuromodulation Therapy Devices Average Price by Company (2021–2026)
2.6 Key Manufacturers Adaptive Neuromodulation Therapy Devices Manufacturing Base and Headquarters
2.7 Key Manufacturers Adaptive Neuromodulation Therapy Devices Product Offerings
2.8 Key Manufacturers Start of Mass Production of Adaptive Neuromodulation Therapy Devices
2.9 Adaptive Neuromodulation Therapy Devices Market Competitive Analysis
2.9.1 Adaptive Neuromodulation Therapy Devices Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Adaptive Neuromodulation Therapy Devices Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Adaptive Neuromodulation Therapy Devices revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Adaptive Neuromodulation Therapy Devices Market Classification
3.1 Introduction by Type
3.1.1 Single-channel
3.1.2 Dual Channels
3.1.3 Global Adaptive Neuromodulation Therapy Devices Sales Value by Type
3.1.3.1 Global Adaptive Neuromodulation Therapy Devices Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global Adaptive Neuromodulation Therapy Devices Sales Value, by Type (2021–2032)
3.1.3.3 Global Adaptive Neuromodulation Therapy Devices Sales Value, by Type (%), 2021–2032
3.1.4 Global Adaptive Neuromodulation Therapy Devices Sales Volume by Type
3.1.4.1 Global Adaptive Neuromodulation Therapy Devices Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Adaptive Neuromodulation Therapy Devices Sales Volume, by Type (2021–2032)
3.1.4.3 Global Adaptive Neuromodulation Therapy Devices Sales Volume, by Type (%), 2021–2032
3.1.5 Global Adaptive Neuromodulation Therapy Devices Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Epilepsy
4.1.2 Parkinson's Disease (PD)
4.1.3 Mixed urinary incontinence (MUI)
4.1.4 Other
4.2 Global Adaptive Neuromodulation Therapy Devices Sales Value by Application
4.2.1 Global Adaptive Neuromodulation Therapy Devices Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Adaptive Neuromodulation Therapy Devices Sales Value, by Application (2021–2032)
4.2.3 Global Adaptive Neuromodulation Therapy Devices Sales Value, by Application (%), 2021–2032
4.3 Global Adaptive Neuromodulation Therapy Devices Sales Volume by Application
4.3.1 Global Adaptive Neuromodulation Therapy Devices Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Adaptive Neuromodulation Therapy Devices Sales Volume, by Application (2021–2032)
4.3.3 Global Adaptive Neuromodulation Therapy Devices Sales Volume, by Application (%), 2021–2032
4.4 Global Adaptive Neuromodulation Therapy Devices Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Adaptive Neuromodulation Therapy Devices Sales Value by Region
5.1.1 Global Adaptive Neuromodulation Therapy Devices Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Adaptive Neuromodulation Therapy Devices Sales Value by Region (2021–2026)
5.1.3 Global Adaptive Neuromodulation Therapy Devices Sales Value by Region (2027–2032)
5.1.4 Global Adaptive Neuromodulation Therapy Devices Sales Value by Region (%), 2021–2032
5.2 Global Adaptive Neuromodulation Therapy Devices Sales Volume by Region
5.2.1 Global Adaptive Neuromodulation Therapy Devices Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Adaptive Neuromodulation Therapy Devices Sales Volume by Region (2021–2026)
5.2.3 Global Adaptive Neuromodulation Therapy Devices Sales Volume by Region (2027–2032)
5.2.4 Global Adaptive Neuromodulation Therapy Devices Sales Volume by Region (%), 2021–2032
5.3 Global Adaptive Neuromodulation Therapy Devices Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Adaptive Neuromodulation Therapy Devices Sales Value, 2021–2032
5.4.2 North America Adaptive Neuromodulation Therapy Devices Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Adaptive Neuromodulation Therapy Devices Sales Value, 2021–2032
5.5.2 Europe Adaptive Neuromodulation Therapy Devices Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Adaptive Neuromodulation Therapy Devices Sales Value, 2021–2032
5.6.2 Asia Pacific Adaptive Neuromodulation Therapy Devices Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Adaptive Neuromodulation Therapy Devices Sales Value, 2021–2032
5.7.2 South America Adaptive Neuromodulation Therapy Devices Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Adaptive Neuromodulation Therapy Devices Sales Value, 2021–2032
5.8.2 Middle East & Africa Adaptive Neuromodulation Therapy Devices Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Adaptive Neuromodulation Therapy Devices Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Adaptive Neuromodulation Therapy Devices Sales Value and Sales Volume
6.2.1 Key Countries/Regions Adaptive Neuromodulation Therapy Devices Sales Value, 2021–2032
6.2.2 Key Countries/Regions Adaptive Neuromodulation Therapy Devices Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Adaptive Neuromodulation Therapy Devices Sales Value, 2021–2032
6.3.2 United States Adaptive Neuromodulation Therapy Devices Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Adaptive Neuromodulation Therapy Devices Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Adaptive Neuromodulation Therapy Devices Sales Value, 2021–2032
6.4.2 Europe Adaptive Neuromodulation Therapy Devices Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Adaptive Neuromodulation Therapy Devices Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Adaptive Neuromodulation Therapy Devices Sales Value, 2021–2032
6.5.2 China Adaptive Neuromodulation Therapy Devices Sales Value by Type (%), 2025 vs 2032
6.5.3 China Adaptive Neuromodulation Therapy Devices Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Adaptive Neuromodulation Therapy Devices Sales Value, 2021–2032
6.6.2 Japan Adaptive Neuromodulation Therapy Devices Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Adaptive Neuromodulation Therapy Devices Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Adaptive Neuromodulation Therapy Devices Sales Value, 2021–2032
6.7.2 South Korea Adaptive Neuromodulation Therapy Devices Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Adaptive Neuromodulation Therapy Devices Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Adaptive Neuromodulation Therapy Devices Sales Value, 2021–2032
6.8.2 Southeast Asia Adaptive Neuromodulation Therapy Devices Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Adaptive Neuromodulation Therapy Devices Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Adaptive Neuromodulation Therapy Devices Sales Value, 2021–2032
6.9.2 India Adaptive Neuromodulation Therapy Devices Sales Value by Type (%), 2025 vs 2032
6.9.3 India Adaptive Neuromodulation Therapy Devices Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Medtronic plc
7.1.1 Medtronic plc Company Information
7.1.2 Medtronic plc Introduction and Business Overview
7.1.3 Medtronic plc Adaptive Neuromodulation Therapy Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Medtronic plc Adaptive Neuromodulation Therapy Devices Product Offerings
7.1.5 Medtronic plc Recent Developments
7.2 Amber Therapeutics
7.2.1 Amber Therapeutics Company Information
7.2.2 Amber Therapeutics Introduction and Business Overview
7.2.3 Amber Therapeutics Adaptive Neuromodulation Therapy Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Amber Therapeutics Adaptive Neuromodulation Therapy Devices Product Offerings
7.2.5 Amber Therapeutics Recent Developments
7.3 Newronika SPA
7.3.1 Newronika SPA Company Information
7.3.2 Newronika SPA Introduction and Business Overview
7.3.3 Newronika SPA Adaptive Neuromodulation Therapy Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Newronika SPA Adaptive Neuromodulation Therapy Devices Product Offerings
7.3.5 Newronika SPA Recent Developments
7.4 Genlight
7.4.1 Genlight Company Information
7.4.2 Genlight Introduction and Business Overview
7.4.3 Genlight Adaptive Neuromodulation Therapy Devices Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Genlight Adaptive Neuromodulation Therapy Devices Product Offerings
7.4.5 Genlight Recent Developments
8 Industry Chain Analysis
8.1 Adaptive Neuromodulation Therapy Devices Industrial Chain
8.2 Adaptive Neuromodulation Therapy Devices Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Adaptive Neuromodulation Therapy Devices Sales Model
8.5.2 Sales Channels
8.5.3 Adaptive Neuromodulation Therapy Devices Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Adaptive Neuromodulation Therapy Devices Market Trends
Table 2. Adaptive Neuromodulation Therapy Devices Market Drivers & Opportunities
Table 3. Adaptive Neuromodulation Therapy Devices Market Challenges
Table 4. Adaptive Neuromodulation Therapy Devices Market Restraints
Table 5. Global Adaptive Neuromodulation Therapy Devices Revenue by Company (US$ Million), 2021–2026
Table 6. Global Adaptive Neuromodulation Therapy Devices Revenue Market Share by Company (2021–2026)
Table 7. Global Adaptive Neuromodulation Therapy Devices Sales Volume by Company (Units), 2021–2026
Table 8. Global Adaptive Neuromodulation Therapy Devices Sales Volume Market Share by Company (2021–2026)
Table 9. Global Market Adaptive Neuromodulation Therapy Devices Price by Company (K US$/Unit), 2021–2026
Table 10. Key Manufacturers Adaptive Neuromodulation Therapy Devices Manufacturing Base and Headquarters
Table 11. Key Manufacturers Adaptive Neuromodulation Therapy Devices Product Type
Table 12. Key Manufacturers Start of Mass Production of Adaptive Neuromodulation Therapy Devices
Table 13. Global Adaptive Neuromodulation Therapy Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Adaptive Neuromodulation Therapy Devices revenue, 2025
Table 15. Mergers & Acquisitions and Expansion Plans
Table 16. Global Adaptive Neuromodulation Therapy Devices Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 17. Global Adaptive Neuromodulation Therapy Devices Sales Value by Type (US$ Million), 2021–2026
Table 18. Global Adaptive Neuromodulation Therapy Devices Sales Value by Type (US$ Million), 2027–2032
Table 19. Global Adaptive Neuromodulation Therapy Devices Sales Market Share in Value by Type (2021–2026)
Table 20. Global Adaptive Neuromodulation Therapy Devices Sales Market Share in Value by Type (2027–2032)
Table 21. Global Adaptive Neuromodulation Therapy Devices Sales Volume by Type: 2021 vs 2025 vs 2032 (Units)
Table 22. Global Adaptive Neuromodulation Therapy Devices Sales Volume by Type (Units), 2021–2026
Table 23. Global Adaptive Neuromodulation Therapy Devices Sales Volume by Type (Units), 2027–2032
Table 24. Global Adaptive Neuromodulation Therapy Devices Sales Market Share in Volume by Type (2021–2026)
Table 25. Global Adaptive Neuromodulation Therapy Devices Sales Market Share in Volume by Type (2027–2032)
Table 26. Global Adaptive Neuromodulation Therapy Devices Price by Type (K US$/Unit), 2021–2026
Table 27. Global Adaptive Neuromodulation Therapy Devices Price by Type (K US$/Unit), 2027–2032
Table 28. Global Adaptive Neuromodulation Therapy Devices Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. Global Adaptive Neuromodulation Therapy Devices Sales Value by Application (US$ Million), 2021–2026
Table 30. Global Adaptive Neuromodulation Therapy Devices Sales Value by Application (US$ Million), 2027–2032
Table 31. Global Adaptive Neuromodulation Therapy Devices Sales Market Share in Value by Application (2021–2026)
Table 32. Global Adaptive Neuromodulation Therapy Devices Sales Market Share in Value by Application (2027–2032)
Table 33. Global Adaptive Neuromodulation Therapy Devices Sales Volume by Application: 2021 vs 2025 vs 2032 (Units)
Table 34. Global Adaptive Neuromodulation Therapy Devices Sales Volume by Application (Units), 2021–2026
Table 35. Global Adaptive Neuromodulation Therapy Devices Sales Volume by Application (Units), 2027–2032
Table 36. Global Adaptive Neuromodulation Therapy Devices Sales Market Share in Volume by Application (2021–2026)
Table 37. Global Adaptive Neuromodulation Therapy Devices Sales Market Share in Volume by Application (2027–2032)
Table 38. Global Adaptive Neuromodulation Therapy Devices Price by Application (K US$/Unit), 2021–2026
Table 39. Global Adaptive Neuromodulation Therapy Devices Price by Application (K US$/Unit), 2027–2032
Table 40. Global Adaptive Neuromodulation Therapy Devices Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 41. Global Adaptive Neuromodulation Therapy Devices Sales Value by Region (US$ Million), 2021–2026
Table 42. Global Adaptive Neuromodulation Therapy Devices Sales Value by Region (US$ Million), 2027–2032
Table 43. Global Adaptive Neuromodulation Therapy Devices Sales Value by Region (%), 2021–2026
Table 44. Global Adaptive Neuromodulation Therapy Devices Sales Value by Region (%), 2027–2032
Table 45. Global Adaptive Neuromodulation Therapy Devices Sales Volume by Region (Units): 2021 vs 2025 vs 2032
Table 46. Global Adaptive Neuromodulation Therapy Devices Sales Volume by Region (Units), 2021–2026
Table 47. Global Adaptive Neuromodulation Therapy Devices Sales Volume by Region (Units), 2027–2032
Table 48. Global Adaptive Neuromodulation Therapy Devices Sales Volume by Region (%), 2021–2026
Table 49. Global Adaptive Neuromodulation Therapy Devices Sales Volume by Region (%), 2027–2032
Table 50. Global Adaptive Neuromodulation Therapy Devices Average Price by Region (K US$/Unit), 2021–2026
Table 51. Global Adaptive Neuromodulation Therapy Devices Average Price by Region (K US$/Unit), 2027–2032
Table 52. Key Countries/Regions Adaptive Neuromodulation Therapy Devices Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 53. Key Countries/Regions Adaptive Neuromodulation Therapy Devices Sales Value, (US$ Million), 2021–2026
Table 54. Key Countries/Regions Adaptive Neuromodulation Therapy Devices Sales Value, (US$ Million), 2027–2032
Table 55. Key Countries/Regions Adaptive Neuromodulation Therapy Devices Sales Volume, (Units), 2021–2026
Table 56. Key Countries/Regions Adaptive Neuromodulation Therapy Devices Sales Volume, (Units), 2027–2032
Table 57. Medtronic plc Company Information
Table 58. Medtronic plc Introduction and Business Overview
Table 59. Medtronic plc Adaptive Neuromodulation Therapy Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 60. Medtronic plc Adaptive Neuromodulation Therapy Devices Product Offerings
Table 61. Medtronic plc Recent Developments
Table 62. Amber Therapeutics Company Information
Table 63. Amber Therapeutics Introduction and Business Overview
Table 64. Amber Therapeutics Adaptive Neuromodulation Therapy Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 65. Amber Therapeutics Adaptive Neuromodulation Therapy Devices Product Offerings
Table 66. Amber Therapeutics Recent Developments
Table 67. Newronika SPA Company Information
Table 68. Newronika SPA Introduction and Business Overview
Table 69. Newronika SPA Adaptive Neuromodulation Therapy Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 70. Newronika SPA Adaptive Neuromodulation Therapy Devices Product Offerings
Table 71. Newronika SPA Recent Developments
Table 72. Genlight Company Information
Table 73. Genlight Introduction and Business Overview
Table 74. Genlight Adaptive Neuromodulation Therapy Devices Sales (Units), Revenue (US$ Million), Price (K US$/Unit) and Gross Margin (2021–2026)
Table 75. Genlight Adaptive Neuromodulation Therapy Devices Product Offerings
Table 76. Genlight Recent Developments
Table 77. Key Raw Materials Lists
Table 78. Key Suppliers of Raw Materials Lists
Table 79. Adaptive Neuromodulation Therapy Devices Downstream Customers
Table 80. Adaptive Neuromodulation Therapy Devices Distributors List
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Adaptive Neuromodulation Therapy Devices Product Picture
Figure 2. Global Adaptive Neuromodulation Therapy Devices Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Adaptive Neuromodulation Therapy Devices Sales Value (US$ Million), 2021–2032
Figure 4. Global Adaptive Neuromodulation Therapy Devices Sales Volume (Units), 2021–2032
Figure 5. Global Adaptive Neuromodulation Therapy Devices Sales Price (K US$/Unit), 2021–2032
Figure 6. Adaptive Neuromodulation Therapy Devices Report Years Considered
Figure 7. Global Adaptive Neuromodulation Therapy Devices Players Revenue Ranking (US$ Million), 2025
Figure 8. Global Adaptive Neuromodulation Therapy Devices Sales Volume Ranking of Players (Units), 2025
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Adaptive Neuromodulation Therapy Devices Revenue in 2025
Figure 10. Adaptive Neuromodulation Therapy Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 11. Single-channel Picture
Figure 12. Dual Channels Picture
Figure 13. Global Adaptive Neuromodulation Therapy Devices Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Adaptive Neuromodulation Therapy Devices Sales Value Market Share by Type, 2025 & 2032
Figure 15. Global Adaptive Neuromodulation Therapy Devices Sales Volume by Type (Units), 2021 vs 2025 vs 2032
Figure 16. Global Adaptive Neuromodulation Therapy Devices Sales Volume Market Share by Type, 2025 & 2032
Figure 17. Global Adaptive Neuromodulation Therapy Devices Price by Type (K US$/Unit), 2021–2032
Figure 18. Product Picture of Epilepsy
Figure 19. Product Picture of Parkinson's Disease (PD)
Figure 20. Product Picture of Mixed urinary incontinence (MUI)
Figure 21. Product Picture of Other
Figure 22. Global Adaptive Neuromodulation Therapy Devices Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 23. Global Adaptive Neuromodulation Therapy Devices Sales Value Market Share by Application, 2025 & 2032
Figure 24. Global Adaptive Neuromodulation Therapy Devices Sales Volume by Application (Units), 2021 vs 2025 vs 2032
Figure 25. Global Adaptive Neuromodulation Therapy Devices Sales Volume Market Share by Application, 2025 & 2032
Figure 26. Global Adaptive Neuromodulation Therapy Devices Price by Application (K US$/Unit), 2021–2032
Figure 27. North America Adaptive Neuromodulation Therapy Devices Sales Value (US$ Million), 2021–2032
Figure 28. North America Adaptive Neuromodulation Therapy Devices Sales Value by Country (%), 2025 vs 2032
Figure 29. Europe Adaptive Neuromodulation Therapy Devices Sales Value (US$ Million), 2021–2032
Figure 30. Europe Adaptive Neuromodulation Therapy Devices Sales Value by Country (%), 2025 vs 2032
Figure 31. Asia Pacific Adaptive Neuromodulation Therapy Devices Sales Value (US$ Million), 2021–2032
Figure 32. Asia Pacific Adaptive Neuromodulation Therapy Devices Sales Value by Region (%), 2025 vs 2032
Figure 33. South America Adaptive Neuromodulation Therapy Devices Sales Value (US$ Million), 2021–2032
Figure 34. South America Adaptive Neuromodulation Therapy Devices Sales Value by Country (%), 2025 vs 2032
Figure 35. Middle East & Africa Adaptive Neuromodulation Therapy Devices Sales Value (US$ Million), 2021–2032
Figure 36. Middle East & Africa Adaptive Neuromodulation Therapy Devices Sales Value by Country (%), 2025 vs 2032
Figure 37. Key Countries/Regions Adaptive Neuromodulation Therapy Devices Sales Value (%), 2021–2032
Figure 38. Key Countries/Regions Adaptive Neuromodulation Therapy Devices Sales Volume (%), 2021–2032
Figure 39. United States Adaptive Neuromodulation Therapy Devices Sales Value (US$ Million), 2021–2032
Figure 40. United States Adaptive Neuromodulation Therapy Devices Sales Value by Type (%), 2025 vs 2032
Figure 41. United States Adaptive Neuromodulation Therapy Devices Sales Value by Application (%), 2025 vs 2032
Figure 42. Europe Adaptive Neuromodulation Therapy Devices Sales Value (US$ Million), 2021–2032
Figure 43. Europe Adaptive Neuromodulation Therapy Devices Sales Value by Type (%), 2025 vs 2032
Figure 44. Europe Adaptive Neuromodulation Therapy Devices Sales Value by Application (%), 2025 vs 2032
Figure 45. China Adaptive Neuromodulation Therapy Devices Sales Value (US$ Million), 2021–2032
Figure 46. China Adaptive Neuromodulation Therapy Devices Sales Value by Type (%), 2025 vs 2032
Figure 47. China Adaptive Neuromodulation Therapy Devices Sales Value by Application (%), 2025 vs 2032
Figure 48. Japan Adaptive Neuromodulation Therapy Devices Sales Value (US$ Million), 2021–2032
Figure 49. Japan Adaptive Neuromodulation Therapy Devices Sales Value by Type (%), 2025 vs 2032
Figure 50. Japan Adaptive Neuromodulation Therapy Devices Sales Value by Application (%), 2025 vs 2032
Figure 51. South Korea Adaptive Neuromodulation Therapy Devices Sales Value (US$ Million), 2021–2032
Figure 52. South Korea Adaptive Neuromodulation Therapy Devices Sales Value by Type (%), 2025 vs 2032
Figure 53. South Korea Adaptive Neuromodulation Therapy Devices Sales Value by Application (%), 2025 vs 2032
Figure 54. Southeast Asia Adaptive Neuromodulation Therapy Devices Sales Value (US$ Million), 2021–2032
Figure 55. Southeast Asia Adaptive Neuromodulation Therapy Devices Sales Value by Type (%), 2025 vs 2032
Figure 56. Southeast Asia Adaptive Neuromodulation Therapy Devices Sales Value by Application (%), 2025 vs 2032
Figure 57. India Adaptive Neuromodulation Therapy Devices Sales Value (US$ Million), 2021–2032
Figure 58. India Adaptive Neuromodulation Therapy Devices Sales Value by Type (%), 2025 vs 2032
Figure 59. India Adaptive Neuromodulation Therapy Devices Sales Value by Application (%), 2025 vs 2032
Figure 60. Adaptive Neuromodulation Therapy Devices Industrial Chain
Figure 61. Adaptive Neuromodulation Therapy Devices Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Adaptive Neuromodulation Therapy Devices market?
The top companies in the global Adaptive Neuromodulation Therapy Devices market are Medtronic plc、Amber Therapeutics、Newronika SPA.
Related Reports
Global Adaptive Neuromodulation Therapy Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Adaptive Neuromodulation Therapy Devices market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 74
USD 4250.00
(Single User License)
Global Adaptive Neuromodulation Therapy Devices Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Adaptive Neuromodulation Therapy Devices market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 122
USD 4900.00
(Single User License)
Global Adaptive Neuromodulation Therapy Devices Market Research Report 2026
The global Adaptive Neuromodulation Therapy Devices market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-15
Pages: 90
USD 2900.00
(Single User License)
Global Adaptive Neuromodulation Therapy Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Adaptive Neuromodulation Therapy Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 117
USD 4900.00
(Single User License)
Global Adaptive Neuromodulation Therapy Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Adaptive Neuromodulation Therapy Devices market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 71
USD 4250.00
(Single User License)
Adaptive Neuromodulation Therapy Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Adaptive Neuromodulation Therapy Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 80
USD 3950.00
(Single User License)
Global Adaptive Neuromodulation Therapy Devices Market Research Report 2025
The global market for Adaptive Neuromodulation Therapy Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 77
USD 2900.00
(Single User License)
Global and United States Adaptive Neuromodulation Therapy Devices Market Report & Forecast 2024-2030
Deep brain stimulation is an established technique for the treatment of movement disorders related to neurodegenerative diseases such as Parkinson's disease (PD) and essential tremor (ET). Its application seems also feasible for the treatment of neuropsychiatric disorders such as treatment resistant depression (TRD) and Tourette's syndrome (TS). In a typical deep brain stimulation system, the amount of current delivered to the patients is constant and regulated by the physician. Conversely, an adaptive deep brain stimulation system (aDBS) is a closed loop system that adjusts the stimulation parameters according to biomarkers which reflect the patient's clinical state.
Published Date: 2024-07-01
Pages: 88
USD 4350.00
(Single User License)
Global Adaptive Neuromodulation Therapy Devices Market Research Report 2024
Deep brain stimulation is an established technique for the treatment of movement disorders related to neurodegenerative diseases such as Parkinson's disease (PD) and essential tremor (ET). Its application seems also feasible for the treatment of neuropsychiatric disorders such as treatment resistant depression (TRD) and Tourette's syndrome (TS). In a typical deep brain stimulation system, the amount of current delivered to the patients is constant and regulated by the physician. Conversely, an adaptive deep brain stimulation system (aDBS) is a closed loop system that adjusts the stimulation parameters according to biomarkers which reflect the patient's clinical state.
Published Date: 2024-07-01
Pages: 74
USD 2900.00
(Single User License)
Global Adaptive Neuromodulation Therapy Devices Market Insights, Forecast to 2030
Deep brain stimulation is an established technique for the treatment of movement disorders related to neurodegenerative diseases such as Parkinson's disease (PD) and essential tremor (ET). Its application seems also feasible for the treatment of neuropsychiatric disorders such as treatment resistant depression (TRD) and Tourette's syndrome (TS). In a typical deep brain stimulation system, the amount of current delivered to the patients is constant and regulated by the physician. Conversely, an adaptive deep brain stimulation system (aDBS) is a closed loop system that adjusts the stimulation parameters according to biomarkers which reflect the patient's clinical state.
Published Date: 2024-07-01
Pages: 119
USD 4900.00
(Single User License)
Global Adaptive Neuromodulation Therapy Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Adaptive Neuromodulation Therapy Devices market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 74
USD 4250.00 (Single User License)Global Adaptive Neuromodulation Therapy Devices Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Adaptive Neuromodulation Therapy Devices market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 122
USD 4900.00 (Single User License)Global Adaptive Neuromodulation Therapy Devices Market Research Report 2026
The global Adaptive Neuromodulation Therapy Devices market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-15
Pages: 90
USD 2900.00 (Single User License)Global Adaptive Neuromodulation Therapy Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Adaptive Neuromodulation Therapy Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 117
USD 4900.00 (Single User License)Global Adaptive Neuromodulation Therapy Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Adaptive Neuromodulation Therapy Devices market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 71
USD 4250.00 (Single User License)Adaptive Neuromodulation Therapy Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Adaptive Neuromodulation Therapy Devices was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 80
USD 3950.00 (Single User License)Global Adaptive Neuromodulation Therapy Devices Market Research Report 2025
The global market for Adaptive Neuromodulation Therapy Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 77
USD 2900.00 (Single User License)Global and United States Adaptive Neuromodulation Therapy Devices Market Report & Forecast 2024-2030
Deep brain stimulation is an established technique for the treatment of movement disorders related to neurodegenerative diseases such as Parkinson's disease (PD) and essential tremor (ET). Its application seems also feasible for the treatment of neuropsychiatric disorders such as treatment resistant depression (TRD) and Tourette's syndrome (TS). In a typical deep brain stimulation system, the amount of current delivered to the patients is constant and regulated by the physician. Conversely, an adaptive deep brain stimulation system (aDBS) is a closed loop system that adjusts the stimulation parameters according to biomarkers which reflect the patient's clinical state.
Published: 2024-07-01
Pages: 88
USD 4350.00 (Single User License)Global Adaptive Neuromodulation Therapy Devices Market Research Report 2024
Deep brain stimulation is an established technique for the treatment of movement disorders related to neurodegenerative diseases such as Parkinson's disease (PD) and essential tremor (ET). Its application seems also feasible for the treatment of neuropsychiatric disorders such as treatment resistant depression (TRD) and Tourette's syndrome (TS). In a typical deep brain stimulation system, the amount of current delivered to the patients is constant and regulated by the physician. Conversely, an adaptive deep brain stimulation system (aDBS) is a closed loop system that adjusts the stimulation parameters according to biomarkers which reflect the patient's clinical state.
Published: 2024-07-01
Pages: 74
USD 2900.00 (Single User License)Global Adaptive Neuromodulation Therapy Devices Market Insights, Forecast to 2030
Deep brain stimulation is an established technique for the treatment of movement disorders related to neurodegenerative diseases such as Parkinson's disease (PD) and essential tremor (ET). Its application seems also feasible for the treatment of neuropsychiatric disorders such as treatment resistant depression (TRD) and Tourette's syndrome (TS). In a typical deep brain stimulation system, the amount of current delivered to the patients is constant and regulated by the physician. Conversely, an adaptive deep brain stimulation system (aDBS) is a closed loop system that adjusts the stimulation parameters according to biomarkers which reflect the patient's clinical state.
Published: 2024-07-01
Pages: 119
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now